amsacrine has been researched along with Anaplastic Large-Cell Lymphoma in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fanin, R | 1 |
| Silvestri, F | 1 |
| Geromin, A | 1 |
| Cerno, M | 1 |
| Infanti, L | 1 |
| Zaja, F | 1 |
| Barillari, G | 1 |
| Savignano, C | 1 |
| Rinaldi, C | 1 |
| Damiani, D | 1 |
| Baccarani, M | 1 |
1 other study available for amsacrine and Anaplastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosp | 1997 |